Achieve Life Sciences Earnings
NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 26, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.19
Achieve Life Sciences earnings summary
Achieve Life Sciences is scheduled to report Sep/2026 earnings on Nov 26, 2026, with analysts expecting EPS of $-0.19. In its most recent report on Nov 19, 2026 (Sep/2026), QUIT posted EPS of $-0.28 versus the $-0.19 consensus estimate, a negative surprise of 47.4%. Achieve Life Sciences beat the consensus EPS estimate in 0 of the last 2 quarters, with a median surprise of -43.7%.
Summary generated from market data by MetaCap's automated system. Methodology
QUIT earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 19, 2026 | $-0.19 | $-0.28 | -47.4% | — |
| Nov 12, 2026 | $-0.20 | $-0.28 | -40.0% | -12.0% |
| Aug 11, 2026 | — | $-0.80 | — | — |
| May 12, 2026 | — | $-0.19 | — | — |
| Mar 24, 2026 | — | $-0.23 | — | — |
| Nov 6, 2025 | — | $-0.28 | — | — |
| Aug 7, 2025 | — | $-0.37 | — | — |
| May 13, 2025 | — | $-0.37 | — | — |
| Mar 11, 2025 | — | $-0.37 | — | — |
| Nov 7, 2024 | — | $-0.36 | — | — |
| Aug 13, 2024 | — | $-0.25 | — | — |
| May 9, 2024 | — | $-0.26 | — | — |
| Mar 28, 2024 | — | $-0.23 | — | — |
| Nov 9, 2023 | — | $-0.34 | — | — |
| Aug 14, 2023 | — | $-0.43 | — | — |
| May 9, 2023 | — | $-0.50 | — | — |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.